healthcare
Ensuring the Safety and Well-Being of Everyone
Kersia produces pharmaceutical-grade effervescent disinfectant tablets, ensuring comprehensive disinfection against bacteria, viruses, and fungi. In healthcare, stringent hygiene and thorough disinfection are essential for patient safety, especially in combating hospital-acquired infections. However, conventional methods often struggle against persistent biofilms, which are prevalent in hospital settings. With its expertise, Kersia contributes significantly to hospital hygiene, addressing nosocomial infections and enhancing healthcare safety.
Innovative Advancement against Biofilms
In 2018, Kersia’s Klorkleen (NaDCC) tablets, designed to combat biofilms in hospital environments, became the inaugural product to meet the US Environmental Protection Agency’s (EPA) updated efficacy standards. Achieving an 8-log reduction in pathogen count within 4 minutes, these tablets stand as the sole product to meet this stringent criteria. Effective against a range of pathogens including Clostridium difficile spores, Norovirus, Candida auris, tuberculosis, and carbapenem-resistant Enterobacteriaceae (CRE).
Kersia disinfectant tablets
Simpler to use
Just add one tablet to a litre of water
More powerful
More powerful than bleach, H2O2, Quats, ultraviolet light and PAA
Safer
Do not corrode surfaces or burn the skin
Smaller
Up to 20 times smaller to transport
Sustainable
Fully Biodegradable
Against Biofilms
Effective against Biofilm